ORIGINAL RESEARCH
Published on 18 Aug 2025
Adverse events of pexidartinib for the treatment of TGCT: a real-world disproportionality analysis using FDA Adverse Event Reporting System database
doi 10.3389/fonc.2025.1594585
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Optimizing Cancer Treatment Timing: Balancing Patient Outcomes and Healthcare Efficiency
Optimizing Cancer Treatment Timing: Balancing Patient Outcomes and Healthcare Efficiency
145
Total downloads
2,340
Total views and downloads
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore